Patents by Inventor Michael Haurand

Michael Haurand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroaryl substituted heterocyclyl sulfones
    Patent number: 9926302
    Abstract: The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: March 27, 2018
    Assignee: GRÜNENTHAL GMBH
    Inventors: Stefan Schunk, Melanie Reich, Florian Jakob, Nils Damann, Michael Haurand, Achim Kless, Marc Rogers, Kathy Mackenzie
  • Aryl substituted heterocyclyl sulfones
    Patent number: 9896440
    Abstract: The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: February 20, 2018
    Assignee: GRÜNENTHAL GMBH
    Inventors: Stefan Schunk, Melanie Reich, Florian Jakob, René Michael Koenigs, Nils Damann, Michael Haurand, Marc Rogers, Kathy MacKenzie, Richard Hamlyn
  • Heteroaryl substituted heterocyclyl sulfones
    Patent number: 9879000
    Abstract: The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: January 30, 2018
    Assignee: GRÜNENTHAL GMBH
    Inventors: Stefan Schunk, Melanie Reich, Florian Jakob, Nils Damann, Michael Haurand, Achim Kless, Marc Rogers, Kathy MacKenzie
  • Fluoromethyl-substituted pyrrole carboxamides iv
    Patent number: 9802921
    Abstract: The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: October 31, 2017
    Assignee: GRUENENTHAL GMBH
    Inventors: Melanie Reich, Stefan Schunk, Florian Jakob, Henning Steinhagen, Nils Damann, Michael Haurand, Richard Hamlyn, Marc Rogers, Kathy MacKenzie
  • HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES
    Publication number: 20170121314
    Abstract: The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: January 12, 2017
    Publication date: May 4, 2017
    Applicant: GRÜNENTHAL GMBH
    Inventors: STEFAN SCHUNK, Melanie Reich, Florian Jakob, Nils Damann, Michael Haurand, Achim Kless, Marc Rogers, Kathy Sutton
  • Fluoromethyl-substituted pyrrole carboxamides as CaV2.2 calcium channel blockers
    Patent number: 9562036
    Abstract: The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: February 7, 2017
    Assignee: GRÜNENTHAL GMBH
    Inventors: Melanie Reich, Stefan Schunk, Florian Jakob, Henning Steinhagen, Nils Damann, Michael Haurand, Marc Rogers, Kathy MacKenzie
  • FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES IV
    Publication number: 20160297803
    Abstract: The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: June 14, 2016
    Publication date: October 13, 2016
    Inventors: Melanie REICH, Stefan SCHUNK, Florian JAKOB, Henning STEINHAGEN, Nils DAMANN, Michael HAURAND, Richard HAMLYN, Marc ROGERS, Kathy MACKENZIE
  • FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES AS CAV2.2 CALCIUM CHANNEL BLOCKERS
    Publication number: 20160289214
    Abstract: The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: June 17, 2016
    Publication date: October 6, 2016
    Applicant: GRÜNENTHAL GMBH
    Inventors: Melanie REICH, Stefan SCHUNK, Florian JAKOB, Henning STEINHAGEN, Nils DAMANN, Michael HAURAND, Marc ROGERS, Kathy MACKENZIE
  • FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES III
    Publication number: 20160289186
    Abstract: The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: June 14, 2016
    Publication date: October 6, 2016
    Inventors: Melanie REICH, Stefan SCHUNK, Florian JAKOB, Nils DAMANN, Michael HAURAND, Richard HAMLYN, Marc ROGERS, Kathy MACKENZIE, Philip SKONE
  • Fluoromethyl-substituted pyrrole carboxamides
    Patent number: 9302988
    Abstract: The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: August 29, 2013
    Date of Patent: April 5, 2016
    Assignee: GRÜNENTHAL GMBH
    Inventors: Stefan Schunk, Melanie Reich, Henning Steinhagen, Nils Damann, Michael Haurand, Achim Kless, Philip Skone, Richard Hamlyn, Robert Kirby, Marc Rogers, Kathy Sutton
  • ARYL SUBSTITUTED HETEROCYCLYL SULFONES
    Publication number: 20150291573
    Abstract: The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: April 14, 2015
    Publication date: October 15, 2015
    Applicant: GRÜNENTHAL GMBH
    Inventors: STEFAN SCHUNK, MELANIE REICH, FLORIAN JAKOB, RENÉ MICHAEL KOENIGS, NILS DAMANN, MICHAEL HAURAND, MARC ROGERS, KATHY SUTTON, RICHARD HAMLYN
  • HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES
    Publication number: 20150291572
    Abstract: The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: April 14, 2015
    Publication date: October 15, 2015
    Applicant: GRÜNENTHAL GMBH
    Inventors: STEFAN SCHUNK, MELANIE REICH, FLORIAN JAKOB, NILS DAMANN, MICHAEL HAURAND, ACHIM KLESS, MARC ROGERS, KATHY SUTTON
  • FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES
    Publication number: 20140066426
    Abstract: The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: August 29, 2013
    Publication date: March 6, 2014
    Inventors: Stefan SCHUNK, Melanie REICH, Henning STEINHAGEN, Nils DAMANN, Michael HAURAND, Achim KLESS, Philip SKONE, Richard HAMLYN, Robert KIRBY, Marc ROGERS, Kathy SUTTON
  • Compounds involving mGluR5 receptor regulation and methods of making the compounds
    Patent number: 8318774
    Abstract: 3-((Thiazol-2-yl)amino)propylproiolamide compounds of the formula I: wherein the variables are as defined herein, are useful to prevent or treat a disease or disorder involving mGluR5 receptor regulation. Also disclosed are pharmaceutical compositions containing the compounds and methods of making the compounds.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: November 27, 2012
    Assignee: Gruenenthal GmbH
    Inventors: Michael Haurand, Klaus Schiene, Sven Kühnert, Melanie Reich
  • Substituted propiolic acid amides and their use for producing drugs
    Patent number: 8008304
    Abstract: The present invention relates to substituted propiolic acid amides, methods for the production thereof, medicaments containing these compounds and the use thereof for producing medicaments.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: August 30, 2011
    Assignee: Grüenthal GmbH
    Inventors: Michael Haurand, Klaus Schiene, Sven Kühnert, Melanie Reich, Saskia Zemolka
  • Substituted imidazo[2,1-b]thiazole compounds and uses thereof
    Patent number: 7893069
    Abstract: Substituted imidazo[2,1-b]thiazole compounds corresponding to formula I, a method for producing them, pharmaceutical compositions containing them, and the use thereof for regularing mGluR5 receptors, or for treating or inhibiting disorders or disease states at least partially mediated by mGluR5 receptor such as pain, anxiety attacks, drug or alcohol dependency, and others.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: February 22, 2011
    Assignee: Gruenenthal GmbH
    Inventors: Sven Kuehnert, Saskia Zemolka, Michael Haurand, Klaus Schiene
  • Substituted thiazoles and their use for producing drugs
    Patent number: 7871999
    Abstract: The present invention relates to substituted thiazoles, to methods for the production thereof, to medicaments containing these compounds and to the use thereof for producing medicaments.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: January 18, 2011
    Assignee: Gruenenthal GmbH
    Inventors: Michael Haurand, Klaus Schiene, Sven Kühnert, Melanie Reich
  • Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
    Patent number: 7858613
    Abstract: The invention relates to substituted benzo-condensed cycloheptanone derivatives, to methods for producing them, to drugs containing said compounds and to the use of said compounds for producing drugs.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: December 28, 2010
    Assignee: Gruenenthal GmbH
    Inventors: Claudia Hinze, Robert Frank, Ruth Jostock, Klaus Schiene, Michael Haurand, Hagen-Heinrich Hennies
  • Sulfonylguanidine compounds and pharmaceutical uses thereof
    Patent number: 7671074
    Abstract: Sulfonylguanidine compounds corresponding to the tautomeric formulas I and Ia, a method for producing them, pharmaceutical compositions containing them, and methods of using them to prepare medicaments and for treating various medical conditions. The sulfonylguanidine compounds have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
    Type: Grant
    Filed: May 1, 2007
    Date of Patent: March 2, 2010
    Assignee: Gruenenthal GmbH
    Inventors: Matthias Gerlach, Heinz Uragg, Michael Haurand, Claudia Katharina Puetz, Corinna Sundermann, Boris Chizh
  • Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds
    Patent number: 7662828
    Abstract: Substituted 5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-2-yl and 5,6,7,8-tetrahydro-quinazolin-2-yl compounds, corresponding to formula I processes for the production thereof, pharmaceutical preparations containing these compounds the use thereof for the production of pharmaceutical preparations and related method of treating or inhibiting certain disorders or conditions, including pain.
    Type: Grant
    Filed: October 27, 2006
    Date of Patent: February 16, 2010
    Assignee: Gruenenthal GmbH
    Inventors: Stefan Oberbörsch, Bernd Sundermann, Corinna Sundermann, Michael Haurand, Hagen-Heinrich Hennies, Edward Bijsterveld